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Human embryonic stem cells (hESCs) are attractive cell sources for tissue engineering
and regenerative medicine due to their self-renewal and differentiation ability. Design of
biomaterials with an intrinsic ability that promotes hESC differentiation to the targeted
cell type boasts significant advantages for tissue regeneration. We have previously
developed biomineralized calcium phosphate (CaP) matrices that inherently direct
osteogenic differentiation of hESCs without the need of osteogenic-inducing chemicals
or growth factors. Here, we show that CaP matrix-driven osteogenic differentiation of
hESCs occurs through A2b adenosine receptor (A2bR). The inhibition of the receptor
with an A2bR-specific antagonist attenuated mineralized matrix-mediated osteogenic
differentiation of hESCs. In addition, when cultured on matrices in an environment
deficient of CaP minerals, exogenous adenosine promoted osteogenic differentiation
of hESCs, but was attenuated by the inhibition of A2bR. Such synthetic matrices that
intrinsically support osteogenic commitment of hESCs are not only beneficial for bone
tissue engineering but can also be used as a platform to study the effect of the physical
and chemical cues to the extracellular milieu on stem cell commitment. Insights into
the cell signaling during matrix-induced differentiation of stem cells will also help define
the key processes and enable discovery of new targets that promote differentiation of
pluripotent stem cells for bone tissue engineering.
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inTrODUcTiOn
Human embryonic stem cells (hESCs) have tremendous potential as a cell source for regenerative 
medicine due to their self-renewal and differentiation ability (Wobus and Boheler, 2005). One of 
the major areas of regenerative medicine includes the application of stem cells in tissue engineering 
and reconstruction (Heng et  al., 2004; Marolt et  al., 2012). However, a main challenge in using 
pluripotent stem cells (PSCs) lies in consistently directing them toward a targeted phenotype (Murry 
and Keller, 2008; De Peppo et al., 2013). This often requires complex stepwise in vitro strategies to 
direct differentiation of PSCs (Levi et al., 2012; Li and Niyibizi, 2012; De Peppo et al., 2013; Hynes 
et al., 2014; Phillips et al., 2014).
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Biomaterials containing calcium phosphate (CaP) moieties 
have been recognized for their osteoinductive and osteoconduc-
tive functions and hence been widely used as a scaffold for bone 
tissue engineering both in vitro and in vivo (Yuan et al., 2007; Levi 
et al., 2012; Eyckmans et al., 2013; Inzana et al., 2014; Kobayashi 
et al., 2014). Recently, we have engineered biomineralized CaP 
matrices that intrinsically induce osteogenic differentiation of 
human mesenchymal stem cells (hMSCs), hESCs, and human-
induced pluripotent stem cells (hiPSCs), without the use of 
osteoinductive soluble factors, such as BMPs or dexamethasone 
(Phadke et al., 2012; Kang et al., 2014a,b). These biomineralized 
matrices also support in vivo bone tissue formation, even in the 
absence of any exogenous biologics (Phadke et  al., 2013; Kang 
et al., 2014b; Shih et al., 2015; Wen et al., 2015).
Calcium phosphate-based biomaterials promote osteogenic 
differentiation of progenitor or stem cells through multiple 
mechanisms. This involves the ability of CaP minerals to seques-
ter osteoinductive growth factors, such as bone morphogenetic 
proteins, and/or regulate extracellular Ca2+ and PO4
3−  concen-
trations (Autefage et al., 2009; Lee et al., 2011). This is further 
supported by the findings of significantly increased osteogenic 
differentiation of stem cells when cultured in medium contain-
ing high levels of Ca2+ and PO4
3−  (Chai et al., 2011; Phadke et al., 
2012). Moreover, it has been shown that biomaterials of CaP 
that can easily dissociate into Ca2+ and PO4
3−  can contribute 
to better bone healing (Yuan et al., 2001; Barradas et al., 2013). 
In addition, a study by Wen et  al. (2012) has demonstrated 
the involvement of L-type Ca2+ channels on Ca2+-mediated 
osteogenic differentiation. Recently, we have shown that the 
PO4
3−  of the CaP minerals can promote osteogenic differentia-
tion through A2b adenosine receptor (A2bR) signaling (Shih 
et al., 2014). This finding is consistent with other studies that 
demonstrated the role of adenosine signaling on bone tissue 
formation and osteogenesis of progenitor cells (Costa et  al., 
2011; Takedachi et  al., 2012). For instance, studies by Evans 
et  al. (2006) have shown the involvement of P1 purinergic 
adenosine receptor signaling in bone function. Specifically, it 
has been demonstrated that A2bR is functionally present in 
osteoprogenitor cells and plays a role in osteoblastic differen-
tiation (Gharibi et al., 2011). Similarly, studies by Carroll et al. 
(2012) have shown that A2bR knockout mice had MSCs with 
decreased osteogenic potential, lower bone density, and delayed 
fracture repair (Carroll et al., 2012). Although it has been shown 
that osteogenesis of hMSCs is mediated by the activation of 
A2bR, its role in promoting osteogenic differentiation of PSCs, 
such as hESCs, remains unclear.
In this study, we determine whether the mineralized matrix-
induced osteogenic differentiation of hESCs involves adenosine 
signaling similar to hMSCs. HESCs exhibit a developmentally 
naive phenotype as well as possess a vastly different cell machin-
ery compared to hMSCs (Ulloa-Montoya et  al., 2007; Aranda 
et  al., 2009; Barbet et  al., 2011). Despite the intrinsic differ-
ences between both cell types, we find that A2bR is involved in 
upregulation of genes associated with osteogenesis and increased 
protein expression of osteocalcin (OCN). This underscores the 
importance of A2bR signaling during osteogenic differentiation 
of stem cells with different maturation states.
MaTerials anD MeThODs
PegDa-co-a6aca hydrogel synthesis
Poly(ethylene glycol)-diacrylate (PEGDA; Mn  =  6  kDa), 
N-acryloyl 6-aminocaproic acid (A6ACA), and PEGDA-co-
A6ACA hydrogels were synthesized, as described previously 
(Kang et  al., 2014b). To summarize, 555  mg of A6ACA was 
dissolved in 3 mL of 1M NaOH. Upon neutralization, 60 mg of 
PEGDA was added to yield a precursor solution composed of 
1M A6ACA and 2% (wt/vol) PEGDA. Using 0.15% N,N,N′,N′-
tetramethylethylenediamine (TEMED) and 0.5% ammonium 
persulfate (APS) as the initiator and accelerator, respectively, the 
resulting solution was polymerized within 1-mm glass spacer 
plates (Bio-Rad, catalog number: 165-3311) for 1 h at room tem-
perature (RT) to yield PEDGA-co-A6ACA hydrogels. The 1-mm 
hydrogel sheets were immersed and equilibrated in phosphate 
buffered saline (PBS; pH = 7.4) for 30 min, after which circular 
disks measuring 1 cm2 in area were punched out and incubated 
overnight in PBS.
hydrogel Mineralization and sterilization
Mineralization of PEGDA-co-A6ACA hydrogels was carried out 
as described elsewhere (Phadke et  al., 2012). Briefly, hydrogels 
were equilibrated in deionized (DI) water for 6 h and subsequently 
immersed in modified simulated body fluid (m-SBF; pH = 7.4) 
for 6  h. The ionic concentrations of m-SBF include 142.0  mM 
Na+, 5.0  mM K+, 2.5  mM Ca2+, 1.5  mM Mg2+, 103.0  mM Cl−, 
10.0 mM HCO3
− , 1.0 mM HPO4
2− , and 0.5 mM SO4
2−  (Oyane 
et al., 2003). After briefly rinsing in DI water, the hydrogels were 
immersed in a solution (pH = 5.2) containing 40 mM Ca2+ and 
24 mM HPO4
2−  while rotating on a VWR Mini-shaker at a speed 
of 200 rpm for 45 min at 25°C. Afterwards, the hydrogels were 
briefly rinsed in DI water and reimmersed in m-SBF for 48 h at 
37°C, during which the solution was changed daily. The hydrogels 
were then immersed and equilibrated in PBS for 6 h prior to steri-
lization. Sterilization for both mineralized and non-mineralized 
PEGDA-co-A6ACA hydrogels was carried out by immersion in 
70% ethanol for 3 h, followed by five daily washes in sterile PBS 
for 3 days prior to cell culture.
scanning electron Microscopy and energy 
Dispersive spectra
Scanning electron microscopy (SEM) was performed on flat 
strips of mineralized and non-mineralized matrices. The samples 
were flash-frozen in liquid nitrogen, lyophilized overnight, and 
coated with Iridium for 7 s within a sputter (Emitech, K575X). 
The samples were imaged using scanning electron microscope 
(Philips XL30 ESEM), and also analyzed for elemental spectra 
using its integrated energy dispersive spectra (EDS) system. The 
Ca/P atomic ratio was computed using Oxford Energy Dispersive 
Spectra with INCA software.
cell culture
Human embryonic stem cells (HUES9) were maintained on 
mitotically inactivated mouse embryonic fibroblast (MEF) 
feeder cells with culture medium containing Knockout DMEM 
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(Life Technologies, catalog number: 10829-018) supplemented 
with 10% (vol/vol) Knockout Serum Replacement (KSR; Life 
Technologies, catalog number: 10828-028), 10% (vol/vol) human 
plasmanate (Talecris Biotherapeutics), 1% (vol/vol) non-essential 
amino acids (NEAA), 1% (vol/vol) Gluta-MAX, 1% (vol/vol) peni-
cillin streptomycin, and 55 μM 2-mercaptoethanol (Chang et al., 
2013). The medium was supplemented with basic fibroblast growth 
factor (bFGF; 30 ng/mL) and exchanged with fresh medium daily. 
Cells were enzymatically detached using Accutase (Millipore) and 
regularly passaged upon reaching approximately 80% confluence.
Prior to cell seeding, both mineralized and non-mineralized 
matrices were coated with Matrigel (Corning, catalog number: 
354277) diluted with DMEM (Invitrogen) at a ratio of 1:82 
(298 μL Matrigel diluted with 24.5 mL DMEM) and incubated 
overnight at 4°C. The following day, matrices were incubated in 
medium containing high glucose DMEM, 20% (vol/vol) fetal 
bovine serum [Premium (FBS); Atlanta Biologicals, catalog 
number: S11150], and 1% (vol/vol) penicillin streptomycin for 
24 h at 37°C. Cells were seeded at an initial density of 10,000 cells/
cm2 and cultured in hESC-maintenance medium containing 
bFGF (30  ng/mL) for 1  day. The hESCs were cultured for an 
additional 2 days in hESC-maintenance medium without bFGF. 
The hESCs were subsequently cultured in growth medium (GM) 
containing high glucose DMEM, 4 mM l-glutamine, 10% (vol/
vol) FBS (Gibco), and 1% (vol/vol) penicillin streptomycin. 
Adenosine and PSB 603 were supplemented into growth media 
for cell treatment. Adenosine (Sigma Aldrich) was first dissolved 
in DMEM as 11.2 mM stock solution and filter sterilized by using 
0.22-μm syringe filters. The stock solution was further diluted 
1,000× in growth media to 11.2 μM as the final concentration for 
experiments. 8-[4-[4-(4-chlorophenzyl)piperazide-1-sulfonyl)
phenyl]]-1-propylxanthine (PSB 603) (Tocris Biosciences, catalog 
number: 3198) was dissolved in dimethyl sulfoxide (DMSO) as 
1 mM stock solution and filter sterilized. The stock solution was 
further diluted 10,000× in growth media to 100 nM as the final 
concentration for experiments. All cell cultures were maintained 
at 37°C and 5% CO2.
cell Tracker staining
To visualize cell attachment in 2-D culture, cells were stained 
with CellTracker (Life Technologies, catalog number: C34552) 
at 3, 5, and 8  days postseeding. Cells attached to the matrix 
were stained in 20 μM CellTracker reagent in DMEM at 37°C 
for 30 min. The stained cells were imaged using a fluorescence 
microscope (Carl Zeiss, Axio Observer.A1).
Quantitative real-Time Polymerase  
chain reaction
Samples from two biological experiments were collected and 
pooled together using TRIzol Reagent (Life Technologies, catalog 
number: 15596-018), and RNA extraction was performed using 
phenol–chloroform extraction method. For each sample, 
1 μg of RNA was reverse transcribed to complementary DNA 
(cDNA) using iScript cDNA Synthesis Kit (Bio-Rad, catalog 
number: 17-8891) according to the manufacturer’s instruc-
tions. The synthesized cDNA was analyzed via quantitative 
real-time polymerase chain reaction (qRT-PCR) for osteogenic 
markers, such as OCN, runt-related transcription factor 2 
(RUNX2), and secreted phosphoprotein 1 (SPP1) as well as 
additional genes, including solute carrier family 20 (phosphate 
transporter), member 1 (SLC20a1), and Nanog homeobox 
(NANOG). Primer sequences for each analyzed gene are pro-
vided in Table S1 in Supplementary Material. Reactions were 
performed using SYBR Select Master Mix (Life Technologies, 
catalog number: 4472908) and ABI Prism 7700 Sequence 
Detection (Applied Biosystems). Fold expression values were 
determined by 2−∆∆Ct  after normalizing each target gene with 
respect to the housekeeping gene (GAPDH) within the sample, 
and compared to undifferentiated hESCs as the control that 
was expressed as 1.
immunofluorescent staining
Osteogenic differentiation of hESCs was evaluated by immu-
nofluorescent staining for OCN. Cells were fixed in 4% para-
formaldehyde for 10 min at RT, and incubated in blocking buffer 
composed of 3% (wt/vol) bovine serum albumin (BSA) and 0.1% 
(vol/vol) Triton™ X-100 in PBS for 45 min. The fixed cells were 
incubated overnight with primary antibodies (1:50; mouse mon-
oclonal, Santa Cruz Biotechnology, catalog number: sc-74495) in 
blocking buffer at 4°C. They were then incubated with blocking 
buffer containing secondary antibody (1:100; goat anti-mouse 
Alexa Fluor® 568, Life Technologies, catalog number: A-11004) 
and phalloidin (1:100; Alexa Fluor® 488, Life Technologies, 
catalog number: A12379). Nuclei were counter-stained using 
Hoechst 33342 (2  μg/mL; Life Technologies, catalog number: 
H1399) at RT for 10  min and washed with PBS. The samples 
were mounted onto glass slides and imaged using a fluorescence 
microscope. Images were acquired using an A1 Zeiss Inverted 
microscope and analyzed using ImageJ. Immunofluorescent 
images of all samples were acquired under the linear mode 
and at an exposure time of 1 s. The background was uniformly 
subtracted from all images using a rolling ball radius method and 
value of 750.0 pixels.
statistical analysis
Statistical analyses were carried out using GraphPad Prism® 
(v. 5.00). One-way analysis of variance (ANOVA) along with 
Tukey–Kramer post hoc test was used to compare multiple groups 
at the same time point. Two-tailed Student’s t-test was utilized to 
compare two groups at the same time point. Two-way ANOVA 
with Bonferroni post  hoc test was used to compare multiple 
groups at different time points. From these tests, the p-values 
were determined and asterisks were assigned to denote statistical 
significances for p-values <0.05.
resUlTs
synthesis and characterization of  
non-Mineralized and Mineralized  
PegDa-co-a6aca Matrices
Hydrogel matrices were synthesized by cross-linking 
poly(ethylene glycol)-diacrylate (PEGDA) with N-acryloyl 
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6-aminocaproic acid (A6ACA). Mineralization of matrices 
occurred with the binding of Ca2+ to terminal carboxyl groups 
along the pendant side chain of A6ACA, leading to the subsequent 
nucleation and growth of CaP minerals (Phadke et al., 2010). In 
order to characterize the morphology and elemental composition 
mineralized matrices, SEM and energy dispersive spectra (EDS) 
analyses were performed as shown in Figure 1. The SEM images 
showed the mineralized matrices displaying a continuous layer 
of bound CaP minerals exhibiting a plate-like morphology. The 
elemental spectra analysis confirmed the presence of calcium 
and phosphorous elements in the mineralized matrices with a 
quantified Ca/P ratio of approximately 1:31. As expected, no such 
moieties or peaks distinguishing such elements were observed 
for non-mineralized matrices.
Mineralized Matrix-Driven Osteogenic 
Differentiation of hescs
The hESCs cultured on non-mineralized and mineralized 
matrices in GM were able to adhere and grow on the matrices 
as a function of time (Figure 2). Analysis of the gene expression 
demonstrated a significant upregulation of various osteogenic 
markers, OCN, RUNX2, and SPP1 for hESCs cultured on 
mineralized matrices compared to non-mineralized matrices 
over 21 days (Figure 3A). This is consistent with our previous 
study, which showed significant upregulation of osteogenic 
markers in hESCs cultured on mineralized matrices (Kang 
et  al., 2014b). Immunofluorescent staining for OCN further 
corroborated these findings, where OCN was stained positive 
in hESCs cultured on mineralized matrices in contrast to those 
cultured on non-mineralized matrices (Figure 3B). OCN stain-
ing intensity markedly increased between 14 and 21  days. In 
addition to osteogenic expression, hESCs exhibited a higher 
upregulation of the sodium–phosphate symporter, SLC20a1, 
when cultured on mineralized matrices compared to non-
mineralized matrices (Figure S1A in Supplementary Material). 
Consistent with the differentiation of hESCs, the pluripotency 
marker, NANOG, was found to be downregulated as a func-
tion of time for both non-mineralized and mineralized matrix 
groups (Figure S1B in Supplementary Material). The hESCs 
cultured on mineralized matrices showed higher upregulation 
of A2bR compared to non-mineralized matrices (Figure S2 in 
Supplementary Material).
Mineralized Matrix-assisted Osteogenic 
Differentiation Through a2br signaling
To explore whether adenosine signaling through A2bR is 
involved during osteogenic differentiation of hESCs on mineral-
ized matrices, we used a selective antagonist, 8-[4-[4-(4-chlo-
rophenzyl)piperazide-1-sulfonyl)phenyl]]-1-propylxanthine 
(PSB 603), to block A2bR. As shown in Figure 4A, the presence 
of PSB 603 in the culture medium abrogated the mineralized 
matrix-induced upregulation of osteogenic genes (Figure 4A). 
These observations were further supported by analysis of 
immunofluorescent staining intensity for OCN. The intensity 
FigUre 1 | characterization of non-mineralized and mineralized matrices. Scanning electron microscopy (SEM) images and corresponding energy 
dispersive spectroscopy (EDS) of non-mineralized (NM) and mineralized (M) matrices. Scale bars represent 5 μm. Inset shows high magnification SEM image.  
Scale bar represents 500 nm.
FigUre 2 | Morphology of hescs on non-mineralized and mineralized matrices. Fluorescent images of hESCs stained by CellTracker cultured on 
non-mineralized (NM) and mineralized (M) matrices after 3, 5, and 8 days of culture. Scale bars represent 200 μm.
FigUre 3 | Mineralized matrix-mediated osteogenic differentiation of hescs. (a) Gene expression profiles for OCN, RUNX2, and SPP1 of hESCs on 
non-mineralized (NM) and mineralized (M) matrices after 14 and 21 days of culture. (B) Immunofluorescent staining of osteocalcin, F-actin, and Hoechst for hESCs 
cultured on NM and M matrices in growth medium (GM) after 14 and 21 days. Data are presented as mean ± SEs (n = 3). Two-tailed Student’s t-test was used to 
compare two groups at the same time point. Asterisks denote statistical significances according to p-values (*p < 0.05, **p < 0.01, ***p < 0.001). Scale bars 
represent 100 μm.
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corroborated these findings, where OCN was stained positive 
in hESCs cultured on mineralized matrices in contrast to those 
cultured on non-mineralized matrices (Figure 3B). OCN stain-
ing intensity markedly increased between 14 and 21  days. In 
addition to osteogenic expression, hESCs exhibited a higher 
upregulation of the sodium–phosphate symporter, SLC20a1, 
when cultured on mineralized matrices compared to non-
mineralized matrices (Figure S1A in Supplementary Material). 
Consistent with the differentiation of hESCs, the pluripotency 
marker, NANOG, was found to be downregulated as a func-
tion of time for both non-mineralized and mineralized matrix 
groups (Figure S1B in Supplementary Material). The hESCs 
cultured on mineralized matrices showed higher upregulation 
of A2bR compared to non-mineralized matrices (Figure S2 in 
Supplementary Material).
Mineralized Matrix-assisted Osteogenic 
Differentiation Through a2br signaling
To explore whether adenosine signaling through A2bR is 
involved during osteogenic differentiation of hESCs on mineral-
ized matrices, we used a selective antagonist, 8-[4-[4-(4-chlo-
rophenzyl)piperazide-1-sulfonyl)phenyl]]-1-propylxanthine 
(PSB 603), to block A2bR. As shown in Figure 4A, the presence 
of PSB 603 in the culture medium abrogated the mineralized 
matrix-induced upregulation of osteogenic genes (Figure 4A). 
These observations were further supported by analysis of 
immunofluorescent staining intensity for OCN. The intensity 
FigUre 1 | characterization of non-mineralized and mineralized matrices. Scanning electron microscopy (SEM) images and corresponding energy 
dispersive spectroscopy (EDS) of non-mineralized (NM) and mineralized (M) matrices. Scale bars represent 5 μm. Inset shows high magnification SEM image.  
Scale bar represents 500 nm.
FigUre 2 | Morphology of hescs on non-mineralized and mineralized matrices. Fluorescent images of hESCs stained by CellTracker cultured on 
non-mineralized (NM) and mineralized (M) matrices after 3, 5, and 8 days of culture. Scale bars represent 200 μm.
FigUre 4 | Mineralized matrix-assisted osteogenic differentiation of hescs involves a2br. (a) OCN, RUNX2, and SPP1 gene expressions of hESCs on 
non-mineralized (NM) in growth medium (GM) as well as on mineralized matrices in growth medium (GM) with and without A2bR antagonist, PSB 603. 
Corresponding immunofluorescent staining of osteocalcin, F-actin, and Hoechst for hESCs cultured on NM and M matrices as well on M matrices in presence of 
PSB 603 for (B) 14 and (c) 21 days of culture. Data are presented as mean ± SEs (n = 3). Multiple groups at the same time point were compared by one-way 
ANOVA with Tukey–Kramer post hoc test. Asterisks denote statistical significances according to p-values (*p < 0.05, ***p < 0.001). Scale bars represent 100 μm.
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of OCN was increased for hESCs cultured on mineralized 
matrices after 14 days, but diminished in the presence of PSB 
603 (Figure 4B). A similar finding was observed at 21 days post-
culture (Figure 4C).
exogenous adenosine Promotes 
Osteogenic Differentiation Through a2br
To further substantiate the role of adenosine signaling on 
osteogenic differentiation of hESCs, cells were cultured on 
non-mineralized matrices, devoid of CaP, and exposed to 
culture medium containing adenosine. Results showed sup-
plementation of exogenous adenosine-promoted osteogenic 
differentiation of hESCs on non-mineralized matrices, while 
inhibition of A2bR with PSB 603 led to a downregulation of 
the osteogenic genes, OCN, RUNX2, and SPP1 (Figure  5A). 
In addition, immunofluorescent staining for OCN was highly 
positive for cells cultured on non-mineralized matrices in the 
presence of adenosine, whereas a reduction in the staining 
intensity was observed in other medium conditions after 14 and 
21 days (Figures 5B,C).
FigUre 5 | exogenous adenosine-mediated osteogenic differentiation of hescs through a2br signaling. (a) OCN, RUNX2, and SPP1 gene expressions 
for hESCs on non-mineralized (NM) matrices in growth medium (GM) supplemented with or without adenosine and PSB 603. Corresponding immunofluorescent 
staining of osteocalcin, F-actin, and Hoechst for hESCs on NM matrices after (B) 14 and (c) 21 days of culture. Data are presented as mean ± SEs (n = 3). Multiple 
groups at the same time point were compared by one-way ANOVA with Tukey–Kramer post hoc test. Asterisks denote statistical significances according to p-values 
(*p < 0.05, **p < 0.01, ***p < 0.001). Scale bars represent 100 μm.
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DiscUssiOn
Previously, we have shown that human PSCs, including hESCs, 
can be differentiated into osteoblasts by using matrix-based 
cues from the mineralized biomaterials (Kang et  al., 2014a,b). 
Consistent with these findings, the hESCs on mineralized 
matrices exhibited an upregulation of osteogenic markers in GM 
even in the absence of any osteogenic-inducing soluble factors. 
As evident from the NANOG expression, the cells on both min-
eralized and non-mineralized matrices lost their pluripotency, 
while only these on mineralized matrices underwent significant 
osteogenic differentiation. The observed loss of pluripotency on 
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all matrices is due to the culture conditions, which lack compo-
nents that are known to assist maintenance of pluripotency of 
hESCs (Chang et  al., 2013). Since increased surface roughness 
at the cell–material interface may increase osteogenic differen-
tiation (Faia-Torres et al., 2014), a limitation to this study is the 
extent of how the topology of mineralized matrices contributes 
to osteogenic commitment.
The hESCs on mineralized matrices not only showed an 
upregulation of gene markers that are relevant to osteogenic dif-
ferentiation but also exhibited high levels of OCN, a bone-specific 
protein. The cells on non-mineralized matrices, which lack any 
intrinsic ability to induce osteogenesis, underwent osteogenic 
differentiation when cultured in medium supplemented with 
adenosine. Both mineralized matrix- and exogenous adenosine-
assisted osteogenic differentiations of hESCs were annulled in the 
presence in PSB 603, which is a known pharmacological inhibitor 
of A2bR. Taken together, these results underscore the influence 
of adenosine signaling through A2b receptor on osteogenic dif-
ferentiation of hESCs. These findings are also consistent with our 
previous reports that showed the role of adenosine signaling on 
mineralized matrix-induced osteogenic differentiation of hMSCs 
(Shih et al., 2014). The adenosine signaling mediated by the min-
eralized matrices not only promotes osteogenic differentiation of 
hMSCs but also inhibits their adipogenic differentiation (Kang 
et al., 2015).
The observation that hESCs on the mineralized matrix 
exhibited upregulation of SLC20a1 implies the potential 
contribution of PO4
3−  ions from the CaP minerals toward this 
process. SLC20a1, also known as PiT-1, is a sodium–phosphate 
symporter that transports PO4
3−  ions from the extracellular 
milieu into the cytoplasm. We have previously shown that the 
extracellular PO4
3−  of the CaP minerals play an important role 
in promoting osteogenic differentiation of hMSCs through 
adenosine signaling, where the cellular intake of PO4
3−  is regu-
lated by SLC20a1 (Shih et al., 2014). Previous studies have also 
shown the importance of SLC20a1 in mineralization (Yoshiko 
et al., 2007; Cowan et al., 2012) as well as A2bR in osteogenic 
differentiation (Gharibi et  al., 2011; He et  al., 2013). Despite 
the differences in cell machinery, we find hESCs consistently 
differentiate into osteoblasts and upregulate the phosphate 
transporter, SLC20a1, on CaP matrices in a similar manner to 
hMSCs. Such an upregulation may facilitate PO4
3−  to serve as a 
substrate for the production of adenosine triphosphate (ATP), 
which has been shown to be essential for osteogenic differentia-
tion (Chen et al., 2008). This production of ATP results in a sub-
sequent increase in extracellular adenosine that requires A2bR 
signaling during CaP-directed osteogenic differentiation (Shih 
et al., 2014). Although we did not investigate its role, calcium is 
required during PO4
3− -induced osteogenic differentiation since 
this process is blunted in the absence of CaP crystal formation 
(Khoshniat et al., 2011).
We detected A2bR gene expression in pluripotent hESCs that 
increased as a function of culture time, possibly demonstrating 
the increased role of the receptor during the maturation process. 
Despite the finding that mineralized matrices promote osteogenic 
differentiation of hESCs through A2bR expression, the down-
stream signaling following A2bR expression remains unclear. 
For instance, whether A2bR signaling crosstalks with calcium-
responsive ion channels in ESCs remains to be determined. Studies 
have shown A2bR expression resulted in significant potentiation 
of P-type Ca2+ current (Vacas et al., 2003). A2bR signaling is cou-
pled to the activation of cyclic AMP (cAMP) through Gs proteins, 
leading to stimulation of downstream signaling molecules (Ham 
and Evans, 2012). Furthermore, Hsiao et al. (2008) have demon-
strated the engineering of a G-protein coupled receptor (GPCR) 
with constitutive Gs signaling in murine osteoblasts dramatically 
enhanced bone mass. A study by Siddappa et al. (2008) reported 
the involvement of protein kinase A (PKA), where cAMP/PKA 
signaling induced in vitro osteogenesis of hMSCs and promoted 
in vivo bone formation with cAMP either stimulating or inhibit-
ing osteogenesis in hMSCs, depending on the duration rather 
than the strength of the signal (Siddappa et al., 2010). However, 
cAMP may exert contrasting effects during early versus late stages 
of osteogenic differentiation of murine ESCs by inhibiting dif-
ferentiation at early stages, but is required at later stages (Zhang 
et al., 2012).
To summarize, the results in this study demonstrate that 
CaP-bearing biomineralized PEGDA-co-A6ACA matrices 
direct osteogenic commitment of hESCs via adenosine signal-
ing. Although this study describes the importance of adenosine 
signaling through A2bR in directing ESC osteogenic fate, there is 
warrant for future studies to further elucidate the role of calcium 
and the signaling network that are involved in mediating osteo-
genic differentiation of PSCs on CaP matrices. Further efforts 
to investigate the cellular signaling pathways can shed light on 
our biological understanding of how cells behave in biomaterials 
to expose new targets of regulation and aid in the development 
of novel biomaterials for cell transplantation and bone tissue 
engineering.
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